Suppr超能文献

长期持续使用非甾体抗炎药(NSAIDs)对脊柱关节炎的病情改善作用

Disease-Modifying Effects of Long-Term and Continuous Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Spondyloarthritis.

作者信息

Wong Rebecca S Y

机构信息

Faculty of Medicine, SEGi University, No. 9, Jalan Teknologi, Taman Sains Selangor, Kota Damansara, PJU 5, 47810 Petaling Jaya, Selangor, Malaysia.

出版信息

Adv Pharmacol Sci. 2019 Jan 29;2019:5324170. doi: 10.1155/2019/5324170. eCollection 2019.

Abstract

Spondyloarthritis or spondyloarthropathy (SpA) is a group of related rheumatic disorders, which presents with axial and nonaxial features, affecting structures within the musculoskeletal system, as well as other bodily systems. Both pharmacological and nonpharmacological therapeutic options are available for SpA. For decades, nonsteroidal anti-inflammatory drugs (NSAIDs) have been used as the first-line drugs to treat the disease. Research has shown that other than pain relief, NSAIDs have disease-modifying effects in SpA. However, to achieve these effects, continuous and/or long-term NSAID use is usually required. This review will give an overview of SpA, discuss NSAIDs and their disease-modifying effects in SpA, and highlight some of the important adverse effects of long-term and continuous NSAID use, particularly those related to the gastrointestinal, renal, and cardiovascular systems.

摘要

脊柱关节炎或脊柱关节病(SpA)是一组相关的风湿性疾病,表现为轴向和非轴向特征,影响肌肉骨骼系统以及其他身体系统内的结构。SpA有药物和非药物治疗选择。几十年来,非甾体抗炎药(NSAIDs)一直被用作治疗该疾病的一线药物。研究表明,除了缓解疼痛外,NSAIDs在SpA中具有改善病情的作用。然而,要实现这些效果,通常需要持续和/或长期使用NSAIDs。本综述将概述SpA,讨论NSAIDs及其在SpA中的改善病情作用,并强调长期和持续使用NSAIDs的一些重要不良反应,特别是那些与胃肠道、肾脏和心血管系统相关的不良反应。

相似文献

1
Disease-Modifying Effects of Long-Term and Continuous Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Spondyloarthritis.
Adv Pharmacol Sci. 2019 Jan 29;2019:5324170. doi: 10.1155/2019/5324170. eCollection 2019.
6
Pharmacological management of axial spondyloarthritis in adults.
Expert Opin Pharmacother. 2019 Aug;20(12):1483-1491. doi: 10.1080/14656566.2019.1617853. Epub 2019 May 16.
8
9
Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.
Cochrane Database Syst Rev. 2015 Jul 1(7):CD007789. doi: 10.1002/14651858.CD007789.pub2.

引用本文的文献

1
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study.
Ther Adv Musculoskelet Dis. 2024 Jun 5;16:1759720X241255486. doi: 10.1177/1759720X241255486. eCollection 2024.
2
The modulation effects of the mind-body and physical exercises on the basolateral amygdala-temporal pole pathway on individuals with knee osteoarthritis.
Int J Clin Health Psychol. 2024 Jan-Mar;24(1):100421. doi: 10.1016/j.ijchp.2023.100421. Epub 2023 Nov 22.
3
Frequency and Predictors of Opioid Use in Rheumatoid Arthritis and Seronegative Spondyloarthropathy Patients.
Addict Health. 2022 Oct;14(4):250-255. doi: 10.34172/ahj.2022.1332. Epub 2022 Oct 29.
4
Regenerative Effect of Mesenchymal Stem Cell on Cartilage Damage in a Porcine Model.
Biomedicines. 2023 Jun 24;11(7):1810. doi: 10.3390/biomedicines11071810.
5
Therapeutic application of PPE2 protein of Mycobacterium tuberculosis in inhibiting tissue inflammation.
EMBO Mol Med. 2022 Sep 7;14(9):e14891. doi: 10.15252/emmm.202114891. Epub 2022 Jul 11.
8
Role of intracellular signaling pathways and their inhibitors in the treatment of inflammation.
Inflammopharmacology. 2021 Jun;29(3):617-640. doi: 10.1007/s10787-021-00813-y. Epub 2021 May 17.
9
Marham-Mafasel decrease joint inflammation and IL-1β gene expression in rheumatoid arthritis animal model.
Vet Med Sci. 2021 Jul;7(4):1417-1425. doi: 10.1002/vms3.430. Epub 2021 May 3.
10
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective.
Biochem Pharmacol. 2020 Oct;180:114147. doi: 10.1016/j.bcp.2020.114147. Epub 2020 Jul 10.

本文引用的文献

1
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13.
2
Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update.
Pharmaceuticals (Basel). 2010 Jan 5;3(1):10-18. doi: 10.3390/ph3010010.
3
Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis.
Arthritis Care Res (Hoboken). 2016 Sep;68(9):1320-31. doi: 10.1002/acr.22831. Epub 2016 Jul 27.
7
Role of stem cells in spondyloarthritis: Pathogenesis, treatment and complications.
Hum Immunol. 2015 Oct;76(10):781-8. doi: 10.1016/j.humimm.2015.09.038. Epub 2015 Sep 30.
9
Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review.
Int J Rheum Dis. 2016 Jun;19(6):536-50. doi: 10.1111/1756-185X.12659. Epub 2015 Jul 22.
10
Biological therapies for spondyloarthritis.
Ther Adv Musculoskelet Dis. 2014 Jun;6(3):92-101. doi: 10.1177/1759720X14535512.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验